These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33352757)

  • 1. Cyclic Peptide Mimotopes for the Detection of Serum Anti-ATIC Autoantibody Biomarker in Hepato-Cellular Carcinoma.
    Heo CK; Hwang HM; Lim WH; Lee HJ; Yoo JS; Lim KJ; Cho EW
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33352757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of anti-SF3B1 autoantibody as a diagnostic marker in patients with hepatocellular carcinoma.
    Hwang HM; Heo CK; Lee HJ; Kwak SS; Lim WH; Yoo JS; Yu DY; Lim KJ; Kim JY; Cho EW
    J Transl Med; 2018 Jun; 16(1):177. PubMed ID: 29954402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum anti-EIF3A autoantibody as a potential diagnostic marker for hepatocellular carcinoma.
    Heo CK; Hwang HM; Lee HJ; Kwak SS; Yoo JS; Yu DY; Lim KJ; Lee S; Cho EW
    Sci Rep; 2019 Jul; 9(1):11059. PubMed ID: 31363116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum BRD2 autoantibody in hepatocellular carcinoma and its detection using mimotope peptide‑conjugated BSA.
    Heo CK; Lim WH; Park I; Choi YS; Lim KJ; Cho EW
    Int J Oncol; 2022 Dec; 61(6):. PubMed ID: 36321789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of autoantibody against fatty acid synthase in hepatocellular carcinoma mouse model and its application to diagnosis of HCC.
    Heo CK; Woo MK; Yu DY; Lee JY; Yoo JS; Yoo HS; Ko JH; Kim JM; Choi JY; Kim IG; Paik SG; Cho EW
    Int J Oncol; 2010 Jun; 36(6):1453-9. PubMed ID: 20428769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bifunctional enzyme ATIC promotes propagation of hepatocellular carcinoma by regulating AMPK-mTOR-S6 K1 signaling.
    Li M; Jin C; Xu M; Zhou L; Li D; Yin Y
    Cell Commun Signal; 2017 Dec; 15(1):52. PubMed ID: 29246230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum autoantibody measurement for the detection of hepatocellular carcinoma.
    Middleton CH; Irving W; Robertson JF; Murray A; Parsy-Kowalska CB; Macdonald IK; McElveen J; Allen J; Healey GF; Thomson BJ; Ryder SJ; Holdenrieder S; Chapman CJ
    PLoS One; 2014; 9(8):e103867. PubMed ID: 25093332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early detection of hepatocellular carcinoma using autoantibody profiles from a panel of tumor-associated antigens.
    Koziol JA; Imai H; Dai L; Zhang JY; Tan EM
    Cancer Immunol Immunother; 2018 May; 67(5):835-841. PubMed ID: 29497780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibody response to murine double minute 2 protein in immunodiagnosis of hepatocellular carcinoma.
    Liu M; Zheng SJ; Chen Y; Li N; Ren PF; Dai LP; Duan ZP; Zhang JY
    J Immunol Res; 2014; 2014():906532. PubMed ID: 24955377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral autoimmune response to nucleophosmin in the immunodiagnosis of hepatocellular carcinoma.
    Liu M; Varela-Ramirez A; Li J; Dai L; Aguilera RJ; Zhang JY
    Oncol Rep; 2015 May; 33(5):2245-52. PubMed ID: 25779011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum anti-osteopontin autoantibody as a novel diagnostic and prognostic biomarker in patients with hepatocellular carcinoma.
    Ying X; Zhao Y; Wang JL; Zhou X; Zhao J; He CC; Guo XJ; Jin GH; Wang LJ; Zhu Q; Han SX
    Oncol Rep; 2014 Oct; 32(4):1550-6. PubMed ID: 25109745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATIC inhibits autophagy in hepatocellular cancer through the AKT/FOXO3 pathway and serves as a prognostic signature for modeling patient survival.
    Zhang H; Xia P; Liu J; Chen Z; Ma W; Yuan Y
    Int J Biol Sci; 2021; 17(15):4442-4458. PubMed ID: 34803509
    [No Abstract]   [Full Text] [Related]  

  • 13. A cancer-related protein 14-3-3ζ is a potential tumor-associated antigen in immunodiagnosis of hepatocellular carcinoma.
    Liu M; Liu X; Ren P; Li J; Chai Y; Zheng SJ; Chen Y; Duan ZP; Li N; Zhang JY
    Tumour Biol; 2014 May; 35(5):4247-56. PubMed ID: 24390614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-BIRC5 autoantibody serves as a valuable biomarker for diagnosing AFP-negative hepatocellular carcinoma.
    Li Q; Liu H; Wang H; Xiong W; Dai L; Zhang X; Wang P; Ye H; Shi J; Fang Z; Wang K
    PeerJ; 2024; 12():e17494. PubMed ID: 38832035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma.
    Dai L; Ren P; Liu M; Imai H; Tan EM; Zhang JY
    Clin Immunol; 2014; 152(1-2):127-39. PubMed ID: 24667685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Six autoantibodies as potential serum biomarkers of hepatocellular carcinoma: A prospective multicenter study.
    Okada R; Otsuka Y; Wakabayashi T; Shinoda M; Aoki T; Murakami M; Arizumi S; Yamamoto M; Aramaki O; Takayama T; Wakiyama S; Yanaga K; Amikura K; Kaneko H; Shimada H
    Int J Cancer; 2020 Nov; 147(9):2578-2586. PubMed ID: 32574375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a mimotope for circulating anti-cytokeratin 8/18 antibody and its usage for the diagnosis of breast cancer.
    Heo CK; Hwang HM; Ruem A; Yu DY; Lee JY; Yoo JS; Kim IG; Yoo HS; Oh S; Ko JH; Cho EW
    Int J Oncol; 2013 Jan; 42(1):65-74. PubMed ID: 23128437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Circulating Antibodies to p16 Protein-Derived Peptides in Hepatocellular Carcinoma.
    Xu Y; Gu L; Wang J; Wang Z; Zhang P; Zhang X
    Lab Med; 2020 Nov; 51(6):574-578. PubMed ID: 32195537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Change of circulating antibodies against CD25-derived peptide antigen in hepatocellular carcinoma.
    Wang J; Xu Y; Zhao H; Zhang X
    J Cancer Res Ther; 2017; 13(5):813-816. PubMed ID: 29237909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum DHCR24 Auto-antibody as a new Biomarker for Progression of Hepatitis C.
    Ezzikouri S; Kimura K; Sunagozaka H; Kaneko S; Inoue K; Nishimura T; Hishima T; Kohara M; Tsukiyama-Kohara K
    EBioMedicine; 2015 Jun; 2(6):604-12. PubMed ID: 26288822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.